Drug ID: | NPD4265 |
Drug Name: | |
Molecular Formula: | C20H34O2 |
Canonical SMILES: | OC/C=C(/CC/C=C(/CC/C=C(/CCC=C(C)C)C)CO)C |
Standard InCHI: | InChI=1S/C20H34O2/c1-17(2)8-5-9-18(3)10-6-12-20(16-22)13-7-11-19(4)14-15-21/h8,10,13-14,21-22H,5-7,9,11-12,15-16H2,1-4H3/b18-10+,19-14+,20-13- |
Standard InCHIKey: | SUWYPNNPLSRNPS-UNTSEYQFSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNAP001516 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 5282197 |
ChEBI | |
CAS Number |
Molecular Weight | 306.26 |
ALogP | 3.7134 |
MLogP | 3.44 |
XLogP | 4.287 |
HDA | 2 |
HBD | 2 |
Rotatable Bonds | 17 |
TPSA | 40.46 |
RO5 Violation | 1 |